News | Stroke | March 19, 2019

Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research

Co-founder of iSchemaView led DEFUSE 3 Study that contributed to new AHA/ASA thrombectomy guidelines

 

Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research

March 19, 2019 – iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research Achievement Award, presented by the Clinical Research Forum. The Distinguished Clinical Research Achievement Awards are presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients.

In the DEFUSE 3 study, Albers and his team used iSchemaView’s RAPID advanced medical imaging platform, exclusively, to identify stroke patients who continue to have salvageable brain tissue many hours after stroke onset. By identifying patients who are most likely to benefit from stroke therapies, the DEFUSE 3 study is credited with accelerating the development and testing of new therapeutic options, as well as enabling hospitals to offer life-saving stroke therapies to many patients who arrive after the previous standard six-hour treatment window has elapsed.

Albers is the Coyote Foundation professor of neurology and neurological sciences and professor, by courtesy, of neurosurgery at the Stanford University Medical Center. He is also director of the Stanford Stroke Center. Albers’ primary research focus is the diagnosis, management and prevention of ischemic stroke. He was instrumental in the development of RAPID, a medical imaging platform that allows physicians to identify stroke patients who have salvageable brain tissue. Due to the findings of DEFUSE 3 and other stroke studies that also employed RAPID, the American Heart Association and American Stroke Association changed their treatment guidelines for thrombectomy from six hours after onset to up to 24 hours after onset for patients with salvageable brain tissue.

Following the awards ceremony, Albers will present the results of the DEFUSE 3 study to members of Congress and discuss the critical role of federal funding for clinical research.

Read the article "Brain-Scan Guided Emergency Stroke Treatment Can Save More Lives"

For more information: www.i-rapid.com

Related Content

The Neuroreader software program quantifies brain volume in study participants with TBI

The Neuroreader software program quantifies brain volume in study participants with TBI. Image courtesy of UCLA Health.

News | Clinical Trials | October 29, 2019
October 29, 2019 — A UCLA-led...
NVIDIA and King's College London Debut First Privacy-preserving Federated Learning System

Image courtesy of NVIDIA

News | Artificial Intelligence | October 23, 2019
To help advance medical research while preserving data privacy and improving patient outcomes for brain tumor...
MaxQ AI's Intracranial Hemorrhage Software to be Integrated on Philips CT Systems
News | Artificial Intelligence | October 18, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that its Accipio intracranial hemorrhage (ICH...
Guerbet Signs Agreement With Icometrix for Exclusive Distribution of Icobrain
News | Neuro Imaging | October 16, 2019
Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil...
RSNA Announces Intracranial Hemorrhage AI Challenge
News | Artificial Intelligence | October 08, 2019
The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI)...
Imaging Biometrics and Medical College of Wisconsin Awarded NIH Grant
News | Neuro Imaging | September 09, 2019
Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million...
Neurological Brain Markers Might Detect Risk for Psychotic Disorders

Researchers at the University of Missouri used MRI scans similar to this photo to find neurological markers in the human brain. These markers can be used to detect people at risk for developing psychotic disorders and to understand when this risk has been successfully treated. Image courtesy of Marquette University/John Kerns.

News | Neuro Imaging | September 04, 2019
Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as...
Delaware Imaging Network Now Offers NeuroQuant Brain Imaging MRI Software
News | Neuro Imaging | August 29, 2019
Delaware Imaging Network (DIN), Delaware’s largest network of outpatient medical imaging centers, has added NeuroQuant...
Smoldering Spots in the Brain May Signal Severe MS

NIH researchers found that dark rimmed spots representing ongoing, “smoldering” inflammation, may be a hallmark of more disabling forms of multiple sclerosis. Image courtesy of Reich lab, NIH/NINDS.

News | Neuro Imaging | August 22, 2019
Aided by a high-powered brain scanner and a 3-D printer, National Institutes of Health (NIH) researchers peered inside...
New MRI Technique Captures Brain Changes in Near-real Time

Differences in stiffness between stimulus states. Image courtesy of Patz et al.

News | Neuro Imaging | August 19, 2019
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an...